CPSI Names Mark V. Anquillare to Board of Directors
MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that Mark V. Anquillare has joined the CPSI Board...
News
Brüush Oral Care Inc. Announces 1-for-25 Reverse Stock Split Effective Pre-Market Opening on August 1, 2023
VANCOUVER, BC / ACCESSWIRE / July 31, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), a direct-to-consumer leader in...
MicroVention Celebrates One-Year Anniversary of FRED™ X Flow Diverter with Over 1,000 Patients Treated Across the U.S.
The FRED X Flow Diverter is the Next Generation in Flow Diversion TechnologySAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--#microvention--MicroVention, Inc.,...
The Assistance Fund Opens New Program for Biliary Tract Cancer
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Biliary Tract CancerORLANDO, FL / ACCESSWIRE /...
Wearable Health Solutions’ iHelp MAX (XWI-EC4WHS) Receives Prestigious PTCRB Certification, Securing Its Place Among Top-Performing Cellular Devices
NEWPORT BEACH, CA / ACCESSWIRE / July, 31 2023 / Wearable Health Solutions, Inc. (OTC:WHSI), a provider of innovative personal...
Justin Esposito Discusses His Role As a Life Coach In New Online Interview
MIAMI, FL / ACCESSWIRE / July 31, 2023 / Justin Esposito is a celebrated life coach and fitness instructor. As...
NCQA Unveils New Features for Long-Term Services and Supports Programs
Updates help states, health plans, managed care organizations and long-term care facilities achieve inclusive, equitable and person-centered careWASHINGTON, DC /...
MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today
MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with...
Nym Receives 100% Overall Customer Satisfaction Score in KLAS Research Emerging Solutions Spotlight Report
Healthcare Providers Report Nym’s Engine Improves Revenue Cycle Efficiency and Reduces Labor Costs by Accurately and Instantly Automating Medical CodingNEW...
Rare Element Resources Announces Receipt of NRC Source Material License for Planned Rare Earth Processing and Separation Demonstration Plant
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce that the U.S. Nuclear...
Axial3D Receives FDA Clearance for Axial3D INSIGHT™ Medical Image Segmentation Platform
Cloud-based solution advances personalized healthcare through scalable, personalized 3D solutions driven by artificial intelligence.BELFAST, Northern Ireland--(BUSINESS WIRE)--#healthcareAI--Axial3D, a leader in...
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
PRINCETON, NJ / ACCESSWIRE / July 31, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Marpe Technologies Receives FDA Breakthrough Device Designation for its Revolutionary Dermatology Screening System
CAESAREA, ISRAEL / ACCESSWIRE / July 31, 2023 / Marpe Technologies, a leading innovator in dermatology screening solutions, is thrilled...
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
MELVILLE, NY / ACCESSWIRE / July 31, 2023 / Chronic back pain is a significant issue in the United States,...
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
After the completion of local regulatory approvals, Aytu anticipates exporting to Medomie both of its novel, orally disintegrating, extended-release tablets...
Planet 13 Announces Release Date of Second Quarter 2023 Financial Results
LAS VEGAS, NV / ACCESSWIRE / July 31, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators – And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
Multiple Research Studies Are In Official Application Stage For EPW Curesearch Sites Covering Numerous Protocols And SpecialtiesVANCOUVER, BC / ACCESSWIRE...
Solve GNE and Gradalis Sign Agreement to Develop a Novel Gene Therapy Targeting HIBM
LOS ANGELES, July 31, 2023 (GLOBE NEWSWIRE) -- Solve GNE announced today that it has entered into a sponsored research...
Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference
SAN DIEGO and SUZHOU and SHANGHAI, China, July 31, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company",...
More Than One-Third of Medicaid Members Say Their Health Plan Didn’t Reach Out About Renewing Coverage to Maintain Benefits
Harris Poll/Icario Survey Also Finds That 55% of Members 65-Plus Said Their Plan Hasn't Reached Out to ThemMINNEAPOLIS, July 31,...